Lorcaserin: Difference between revisions

Jump to navigation Jump to search
(#REDIRECT #REDIRECT #REDIRECT)
 
(27 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{CMG}}
#REDIRECT [[Lorcaserin Hydrochloride Hemihydrate]]
==Overview==
Lorcaserin is a weight-loss drug developed by Arena Pharmaceuticals. It has [[serotonergic]] properties and acts as an [[anorectic]].  On 27 June 2012, the [[Food and Drug Administration|FDA]] officially approved lorcaserin for use in the treatment of [[obesity]] for adults with a [[BMI]] equal to or greater than 30 or adults with a BMI of 27 or greater who "have at least one weight-related health condition, such as high [[blood pressure]], [[type 2 diabetes]], or high [[cholesterol]]".
 
==References==
{{Reflist|2}}
 
{{WH}}
{{WS}}

Latest revision as of 21:29, 14 January 2015